D, A., S, H., A, G., & SM, D. (2026). Determinants of response to neoadjuvant chemotherapy in breast cancer: Integrated roles of immune pathways, DNA damage response, and cell cycle regulators. Molecular biology reports, 53(1), . https://doi.org/10.1007/s11033-026-12512-4
Chicago Style (17th ed.) CitationD, Ahdi, Hashemi S, Gholami A, and Derakhshan SM. "Determinants of Response to Neoadjuvant Chemotherapy in Breast Cancer: Integrated Roles of Immune Pathways, DNA Damage Response, and Cell Cycle Regulators." Molecular Biology Reports 53, no. 1 (2026). https://doi.org/10.1007/s11033-026-12512-4.
MLA (9th ed.) CitationD, Ahdi, et al. "Determinants of Response to Neoadjuvant Chemotherapy in Breast Cancer: Integrated Roles of Immune Pathways, DNA Damage Response, and Cell Cycle Regulators." Molecular Biology Reports, vol. 53, no. 1, 2026, https://doi.org/10.1007/s11033-026-12512-4.